Guided Therapeutics (GTHP) Capital Expenditures Growth (5y) (2016 - 2022)
Guided Therapeutics (GTHP) Capital Expenditures Growth (5y) (2016 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.66 Bn | 175.36 Bn | 6.27 Bn |
| 2 | Stryker | 128.55 Bn | 125.68 Bn | 3.81 Bn |
| 3 | Medtronic | 108.38 Bn | 99.16 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.11 Bn | 66.66 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.19 Bn | 43.52 Bn | 1.29 Bn |
| 6 | Dexcom | 28.54 Bn | 27.42 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.09 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.40 Bn | 2.07 Bn |
| 10 | Guided Therapeutics | 20.39 Mn | 20.32 Mn | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 60.16% |
| Mar 31, 2022 | 74.11% |
| Dec 31, 2021 | -7.99% |
| Sep 30, 2021 | -1.92% |
| Jun 30, 2021 | 19.57% |
| Mar 31, 2021 | 15.50% |
| Sep 30, 2020 | -27.86% |
| Jun 30, 2020 | 61.54% |
| Sep 30, 2018 | 53.06% |
| Mar 31, 2018 | -15.88% |
| Sep 30, 2017 | -32.36% |
| Mar 31, 2017 | 62.22% |
| Dec 31, 2016 | 17.72% |
| Sep 30, 2016 | 38.59% |
| Jun 30, 2016 | 13.88% |
| Mar 31, 2016 | -2.38% |